Karyopharm Therapeutics Files Prospectus For Offering $400M Mixed Shelf

Benzinga Newsdesk www.benzinga.com Neutral 93.1%

Neg 0% Neu 93.1% Pos 0%

https://www.sec.gov/Archives/edgar/data/1503802/000119312526204130/d69189ds3.htm

Comments

No comments yet. Be the first!